112 related articles for article (PubMed ID: 660008)
1. Combination chemotherapy with cyclophosphamide (NSC-26 271), methotrexate (NSC-740), and prednisolone (NSC-9 900) (CMP protocol), for metastatic breast cancer.
Umsawasdi T; Nilprabhassorn P
J Med Assoc Thai; 1978 Mar; 61(3):158-61. PubMed ID: 660008
[No Abstract] [Full Text] [Related]
2. A pilot study of sequential combination chemotherapy with adriamycin and cyclophosphamide, and methotrexate, 5-fluorouracil and prednisolone in advanced breast cancer.
Collis CH
Br J Clin Pract; 1978 May; 32(5):139-44. PubMed ID: 666968
[No Abstract] [Full Text] [Related]
3. Cyclical combination chemotherapy in advanced breast cancer.
Edelstyn GA; Marcrae KD
Ann R Coll Surg Engl; 1974 Jun; 54(6):275-6. PubMed ID: 4833779
[No Abstract] [Full Text] [Related]
4. [Remission maintenance with cytostatic long-term therapy in metastatic breast cancer].
Beaufort F
Onkologie; 1982 Aug; 5 Suppl():52-4. PubMed ID: 6813783
[TBL] [Abstract][Full Text] [Related]
5. [Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone].
Raevskiĭ IG
Sov Med; 1976 Aug; (8):112-4. PubMed ID: 1006408
[No Abstract] [Full Text] [Related]
6. Chemotherapy for advanced breast cancer.
Khanna NN; Kumar A; Khanna S; Pant GC; Sanyal B
Indian J Cancer; 1981 Mar; 18(1):59-62. PubMed ID: 7262908
[No Abstract] [Full Text] [Related]
7. Moderately high-dosage methotrexate medication in metastatic breast cancer.
Wils JA
Neth J Med; 1980; 23(2):59-61. PubMed ID: 7374869
[No Abstract] [Full Text] [Related]
8. Cyclic combination chemotherapy for metastatic breast cancer.
Biran S; Krasnokuki D; Hochman A; Brufman G
Isr J Med Sci; 1977 Jun; 13(6):582-6. PubMed ID: 885710
[TBL] [Abstract][Full Text] [Related]
9. Combination versus sequential five-drug chemotherapy in metastatic carcinoma of the breast.
Smalley RV; Murphy S; Huguley CM; Bartolucci AA
Cancer Res; 1976 Nov; 36(11 Pt 1):3911-6. PubMed ID: 975039
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of five drug combination chemotherapy in the management of recurrent carcinoma of the breast.
Lee JM; Abeloff MD; Lenhard RE; Baker RR
Surg Gynecol Obstet; 1974 Jan; 138(1):77-80. PubMed ID: 4809006
[No Abstract] [Full Text] [Related]
11. [Use of "split" courses of combination chemotherapy in breast cancer].
Dymarskiĭ LIu; Aleksandrova GI; Sanchakova AV
Vopr Onkol; 1981; 27(7):82-5. PubMed ID: 7269435
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy in disseminated carcinoma of the breast.
Kaufman S; Goldstein M
Surg Gynecol Obstet; 1973 Jul; 137(1):83-6. PubMed ID: 4714324
[No Abstract] [Full Text] [Related]
13. Disseminated breast carcinoma. Treatment with combination chemotherapy.
Spigel SC; Coltman CA; Costanzi JJ
Arch Intern Med; 1973 Oct; 132(4):575-7. PubMed ID: 4742410
[No Abstract] [Full Text] [Related]
14. [Combination chemotherapy in metastatic breast cancer].
Kuten A; Lev L; Mohaliver J; Robinson E
Harefuah; 1981 Feb; 100(3):118-20. PubMed ID: 7262675
[TBL] [Abstract][Full Text] [Related]
15. Monochemotherapy (Adriamycin) for metastatic breast cancer in progression after sequential hormone-chemotherapy (MAP and CMF). Pilot study.
Pannuti F; Rossi AP; Di Marco AR; Fruet F; Lelli G; Strocchi E; Rocchetta G; Piana E; Martoni A
Panminerva Med; 1981; 23(1):25-8. PubMed ID: 7290722
[No Abstract] [Full Text] [Related]
16. [Cytostatic combination therapy in metastatic breast cancer].
Mouridsen HT
Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
[No Abstract] [Full Text] [Related]
17. [CMF (cyclophosphamide, methotrexate, ftorafur) chemotherapy in advanced breast cancer].
Gottwald G; Szakolczai I
Orv Hetil; 1983 Jan; 124(2):79-84. PubMed ID: 6687491
[No Abstract] [Full Text] [Related]
18. [Chemotherapy of breast cancer].
Wilmanns W; Hartenstein R; Sauer H; Binsack T
Gynakol Rundsch; 1981; 21 Suppl 2():9-22. PubMed ID: 7319304
[No Abstract] [Full Text] [Related]
19. Methotrexate (NSC-740) with citrovorum factor (NSC-3590) rescue, alone and in combination with cyclophosphamide (NSC-26271), in ovarian cancer.
Barlow JJ; Piver MS
Cancer Treat Rep; 1976 May; 60(5):527-33. PubMed ID: 1086714
[TBL] [Abstract][Full Text] [Related]
20. Prolonged clinical benefit with metronomic chemotherapy in patients with metastatic breast cancer.
Orlando L; Cardillo A; Rocca A; Balduzzi A; Ghisini R; Peruzzotti G; Goldhirsch A; D'Alessandro C; Cinieri S; Preda L; Colleoni M
Anticancer Drugs; 2006 Sep; 17(8):961-7. PubMed ID: 16940806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
